Cargando…
Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation
BACKGROUND: Acute cellular rejection (ACR) is a major complication after heart transplantation. Endomyocardial biopsy (EMB) remains the gold standard for its diagnosis, but it has concerning complications. We evaluated the usefulness of speckle tracking echocardiography (STE) and biomarkers for dete...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797113/ https://www.ncbi.nlm.nih.gov/pubmed/33422079 http://dx.doi.org/10.1186/s12947-020-00235-w |
_version_ | 1783634804481196032 |
---|---|
author | Cruz, Cecilia Beatriz Bittencourt Viana Hajjar, Ludhmila A. Bacal, Fernando Lofrano-Alves, Marco S. Lima, Márcio S. M. Abduch, Maria C. Viera, Marcelo L. C. Chiang, Hsu P. Salviano, Juliana B. C. da Silva Costa, Isabela Bispo Santos Fukushima, Julia Tizue Sbano, Joao C. N. Mathias, Wilson Tsutsui, Jeane M. |
author_facet | Cruz, Cecilia Beatriz Bittencourt Viana Hajjar, Ludhmila A. Bacal, Fernando Lofrano-Alves, Marco S. Lima, Márcio S. M. Abduch, Maria C. Viera, Marcelo L. C. Chiang, Hsu P. Salviano, Juliana B. C. da Silva Costa, Isabela Bispo Santos Fukushima, Julia Tizue Sbano, Joao C. N. Mathias, Wilson Tsutsui, Jeane M. |
author_sort | Cruz, Cecilia Beatriz Bittencourt Viana |
collection | PubMed |
description | BACKGROUND: Acute cellular rejection (ACR) is a major complication after heart transplantation. Endomyocardial biopsy (EMB) remains the gold standard for its diagnosis, but it has concerning complications. We evaluated the usefulness of speckle tracking echocardiography (STE) and biomarkers for detecting ACR after heart transplantation. METHODS: We prospectively studied 60 transplant patients with normal left and right ventricular systolic function who underwent EMB for surveillance 6 months after transplantation. Sixty age- and sex-matched healthy individuals constituted the control group. Conventional echocardiographic parameters, left ventricular global longitudinal, radial and circumferential strain (LV-GLS, LV-GRS and LV-GCS, respectively), left ventricular systolic twist (LV-twist) and right ventricular free wall longitudinal strain (RV-FWLS) were analyzed just before the procedure. We also measured biomarkers at the same moment. RESULTS: Among the 60 studied patients, 17 (28%) had severe ACR (grade ≥ 2R), and 43 (72%) had no significant ACR (grade 0 – 1R). The absolute values of LV-GLS, LV-twist and RV-FWLS were lower in transplant patients with ACR degree ≥ 2 R than in those without ACR (12.5% ± 2.9% vs 14.8% ± 2.3%, p=0.002; 13.9° ± 4.8° vs 17.1° ± 3.2°, p=0.048; 16.6% ± 2.9% vs 21.4%± 3.2%, p < 0.001; respectively), while no differences were observed between the LV-GRS or LV-GCS. All of these parameters were lower in the transplant group without ACR than in the nontransplant control group, except for the LV-twist. Cardiac troponin I levels were significantly higher in patients with significant ACR than in patients without significant ACR [0.19 ng/mL (0.09–1.31) vs 0.05 ng/mL (0.01–0.18), p=0.007]. The combination of troponin with LV-GLS, RV-FWLS and LV-Twist had an area under curve for the detection of ACR of 0.80 (0.68–0.92), 0.89 (0.81–0.93) and 0.79 (0.66–0.92), respectively. CONCLUSION: Heart transplant patients have altered left ventricular dynamics compared with control individuals. The combination of troponin with strain parameters had higher accuracy for the detection of ACR than the isolated variables and this association might select patients with a higher risk for ACR who will benefit from an EMB procedure in the first year after heart transplantation. |
format | Online Article Text |
id | pubmed-7797113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77971132021-01-11 Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation Cruz, Cecilia Beatriz Bittencourt Viana Hajjar, Ludhmila A. Bacal, Fernando Lofrano-Alves, Marco S. Lima, Márcio S. M. Abduch, Maria C. Viera, Marcelo L. C. Chiang, Hsu P. Salviano, Juliana B. C. da Silva Costa, Isabela Bispo Santos Fukushima, Julia Tizue Sbano, Joao C. N. Mathias, Wilson Tsutsui, Jeane M. Cardiovasc Ultrasound Research BACKGROUND: Acute cellular rejection (ACR) is a major complication after heart transplantation. Endomyocardial biopsy (EMB) remains the gold standard for its diagnosis, but it has concerning complications. We evaluated the usefulness of speckle tracking echocardiography (STE) and biomarkers for detecting ACR after heart transplantation. METHODS: We prospectively studied 60 transplant patients with normal left and right ventricular systolic function who underwent EMB for surveillance 6 months after transplantation. Sixty age- and sex-matched healthy individuals constituted the control group. Conventional echocardiographic parameters, left ventricular global longitudinal, radial and circumferential strain (LV-GLS, LV-GRS and LV-GCS, respectively), left ventricular systolic twist (LV-twist) and right ventricular free wall longitudinal strain (RV-FWLS) were analyzed just before the procedure. We also measured biomarkers at the same moment. RESULTS: Among the 60 studied patients, 17 (28%) had severe ACR (grade ≥ 2R), and 43 (72%) had no significant ACR (grade 0 – 1R). The absolute values of LV-GLS, LV-twist and RV-FWLS were lower in transplant patients with ACR degree ≥ 2 R than in those without ACR (12.5% ± 2.9% vs 14.8% ± 2.3%, p=0.002; 13.9° ± 4.8° vs 17.1° ± 3.2°, p=0.048; 16.6% ± 2.9% vs 21.4%± 3.2%, p < 0.001; respectively), while no differences were observed between the LV-GRS or LV-GCS. All of these parameters were lower in the transplant group without ACR than in the nontransplant control group, except for the LV-twist. Cardiac troponin I levels were significantly higher in patients with significant ACR than in patients without significant ACR [0.19 ng/mL (0.09–1.31) vs 0.05 ng/mL (0.01–0.18), p=0.007]. The combination of troponin with LV-GLS, RV-FWLS and LV-Twist had an area under curve for the detection of ACR of 0.80 (0.68–0.92), 0.89 (0.81–0.93) and 0.79 (0.66–0.92), respectively. CONCLUSION: Heart transplant patients have altered left ventricular dynamics compared with control individuals. The combination of troponin with strain parameters had higher accuracy for the detection of ACR than the isolated variables and this association might select patients with a higher risk for ACR who will benefit from an EMB procedure in the first year after heart transplantation. BioMed Central 2021-01-09 /pmc/articles/PMC7797113/ /pubmed/33422079 http://dx.doi.org/10.1186/s12947-020-00235-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cruz, Cecilia Beatriz Bittencourt Viana Hajjar, Ludhmila A. Bacal, Fernando Lofrano-Alves, Marco S. Lima, Márcio S. M. Abduch, Maria C. Viera, Marcelo L. C. Chiang, Hsu P. Salviano, Juliana B. C. da Silva Costa, Isabela Bispo Santos Fukushima, Julia Tizue Sbano, Joao C. N. Mathias, Wilson Tsutsui, Jeane M. Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
title | Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
title_full | Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
title_fullStr | Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
title_full_unstemmed | Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
title_short | Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
title_sort | usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797113/ https://www.ncbi.nlm.nih.gov/pubmed/33422079 http://dx.doi.org/10.1186/s12947-020-00235-w |
work_keys_str_mv | AT cruzceciliabeatrizbittencourtviana usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT hajjarludhmilaa usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT bacalfernando usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT lofranoalvesmarcos usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT limamarciosm usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT abduchmariac usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT vieramarcelolc usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT chianghsup usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT salvianojulianabc usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT dasilvacostaisabelabisposantos usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT fukushimajuliatizue usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT sbanojoaocn usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT mathiaswilson usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation AT tsutsuijeanem usefulnessofspeckletrackingechocardiographyandbiomarkersfordetectingacutecellularrejectionafterhearttransplantation |